Search for other papers by Yan-yu Zhang in
Google Scholar
PubMed
Search for other papers by Xian Zhang in
Google Scholar
PubMed
Search for other papers by Shao-yang Bu in
Google Scholar
PubMed
Search for other papers by Wei-wei Zhang in
Google Scholar
PubMed
Search for other papers by Tian-xiu Li in
Google Scholar
PubMed
Search for other papers by De-cai Zheng in
Google Scholar
PubMed
Search for other papers by Ze-xiang Huang in
Google Scholar
PubMed
Search for other papers by Qian Wang in
Google Scholar
PubMed
via glucocorticoid and then participate in the regulation of gonadal differentiation and sexual reversal. However, the distribution of two kiss -expressing neurons in the brain of sexual reversal teleosts has been poorly studied. The yellowtail
Molecular Reproductive Research Group, Department of Translational Medicine, Lund University, Malmö, Sweden
Institute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden
Search for other papers by Angel Elenkov in
Google Scholar
PubMed
Search for other papers by Irene Leijonhufvud in
Google Scholar
PubMed
Search for other papers by Katerina Vaporidi in
Google Scholar
PubMed
Search for other papers by Åsa Tivesten in
Google Scholar
PubMed
Reproductive Medicine Centre, Skåne University Hospital Malmö, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
included in the study. Exclusion criteria: Smoking, cortisone or interferon treatments in the last 3 months, recent infections or inflammatory diseases, HIV infection anti-diabetic/insulin therapy, opioids, glucocorticoids or any other anti
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Brendan J Nolan in
Google Scholar
PubMed
Search for other papers by Aviva S Frydman in
Google Scholar
PubMed
Search for other papers by Shalem Y Leemaqz in
Google Scholar
PubMed
Search for other papers by Meg Carroll in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Ada S Cheung in
Google Scholar
PubMed
the progesterone, androgen, and glucocorticoid receptors ( 23 ). A retrospective analysis of 92 trans individuals from the United States reported a significantly lower mean total testosterone concentration in the 39 individuals treated with MPA in
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Mette Bøgehave in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Odense, Denmark
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Jørgen Brodersen Gram in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Else-Marie Bladbjerg in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Johannes Jakobsen Sidelmann in
Google Scholar
PubMed
treatment, treated with 5α-reductase inhibitors, oral glucocorticoid steroids, or anticoagulants. We also excluded men with haematocrit > 53%, previous or ongoing malignant disease, prostate-specific antigen > 3 ng/dL, abnormal routine blood samples (thyroid